Microbiology And Immunology

Projects

Projects per year 2008 2015 2020 2021 2022 2023 2029

• 69 Active
• 225 Completed

Projects per year

Search results

• Completed

  Testing inhibitors against flaviviruses

  Xie, X. (PI)

  Integer Bioscience

  4/15/24 → 10/15/24

  Project: Research project

• Testing the efficacy of NITD688 and NITD008 in a cellular assay against 12 dengue virus strains from all 4 serotypes

  Xie, X. (PI)

  Novartis Institute for BioMedical Research

  3/15/24 → 7/31/24

  Project: Research project

• Assessment of Antiviral Activity of MTP Material against Ebola and Marburg in Vitro

  Geisbert, T. (PI)

  FetTech, LLC

  11/1/23 → 4/30/24

  Project: Research project

• A Rickettsia amblyommatis vaccine to prevent transmission of Rickettsia rickettsii by brown dog ticks

  Laroche, M. (PI)

  Centers for Disease Control and Prevention

  9/1/23 → 8/31/24

  Project: Research project

  • Rickettsia Amblyommatis 100%
  • Rocky Mountain Spotted Fever 100%
  • Brown Dog Tick 100%
  • Rickettsia Rickettsii 100%
  • Rickettsia amblyommatis 100%

• A Rickettsia amblyommatis vaccine to prevent transmission of Rickettsia rickettsii by brown dog ticks

  Laroche, M. (PI)

  Centers for Disease Control and Prevention - Non LOC

  9/1/23 → 8/31/24

  Project: Research project

  • Rickettsia Amblyommatis 100%
  • Rocky Mountain Spotted Fever 100%
  • Brown Dog Tick 100%
  • Rickettsia Rickettsii 100%
  • Rickettsia amblyommatis 100%

• Monoclonal Antibody Cocktail for Treatment of Marburg Virus Disease

  Geisbert, T. (PI)

  Abvacc

  8/11/23 → 1/1/24

  Project: Research project

  • Monoclonal Antibody Cocktail 100%
  • Guinea pig 100%
  • Marburg Virus Disease 100%
  • Monoclonal Antibody 100%
  • Guinea Pig 100%

• Development of monoclonal antibody against SARS-CoV-2 variants

  Xie, X. (PI)

  AstraZeneca LP

  6/26/23 → 6/25/24

  Project: Research project

• Evaluate in vivo prophylactic and therapeutic efficacy of a RNAi-based drug against highly pathogenic influenza A (HPIA) virus, H5N1 (A/Viet Nam/1203/2004)

  Tseng, C.-T. (PI)

  Arrowhead Pharmaceuticals, Inc

  6/1/23 → 5/31/24

  Project: Research project

  • Prophylactic Efficacy 100%
  • Therapeutic Efficacy 100%
  • RNA Interference 100%
  • Highly Pathogenic Influenza 100%
  • Vietnam 100%

• Panacea- Relevant to Enhancing the Mission Effectiveness of Military Personnel and Supporting Platforms, Systems, Components, or Materials

  Geisbert, T. (PI)

  Access to Advanced Health Institute

  4/15/23 → 7/31/24

  Project: Research project

• Reimbursement Agreement: Nagasawa & Strillets

  Endsley, J. (PI)

  UNIVERSITY OF VIRGINIA

  4/1/23 → 3/31/24

  Project: Research project

• PROTECT: PROtective host Targeted Engineered CRISPR-CasTherapeutics

  Weaver, S. (PI)

  Lawrence Livermore National Security , LLC

  3/21/23 → 9/30/24

  Project: Research project

• Efficacy of IBT-T03-T, IBT-T03-RCB#19, and IBT-T03-RCB#3 when administered by IV infusion in NHP MARV-Angola challenge model

  Geisbert, T. (PI)

  Abvacc

  3/1/23 → 1/31/24

  Project: Research project

• SARS-CoV-2 therapeutic antibodies

  Xie, X. (PI)

  Aerium Therapeutics

  1/1/23 → 5/1/23

  Project: Research project

• Genetic and Cellular Determinants of individual susceptibility & resistance to Shiga toxins, a family of potent diarrheal disease bacterial toxins

  Torres, A. (PI)

  ABSS Solutions, Inc

  1/1/23 → 9/25/24

  Project: Research project

• Activity of Johnson & Johnson Oral Formulations against HCoV-OC43

  Endsley, M. (PI)

  Johnson and Johnson Consumer, Inc

  1/1/23 → 10/4/24

  Project: Research project

• Fixed - Genetic and Cellular Determinants of individual susceptibility & resistance to Shiga toxins, a family of potent diarrheal disease bacterial toxins

  Torres, A. (PI)

  ABSS Solutions, Inc

  1/1/23 → 9/25/24

  Project: Research project

• MCDC2204-006: Vaccine Development for Protection from Nipah and Hendra Virus Disease

  Geisbert, T. (PI)

  Advanced Technology International

  11/21/22 → 3/17/23

  Project: Research project

• EBOV002, a Phase 1b, Placebo-controlled, Single-center Randomized Clinical Trial to Evaluate the Safety, Tolerability and Immunogenicity of INO-4201 as a Booster Vaccination in Healthy Volunteers Who Have Previously Received the VSV-ZEBOV Vaccine

  Kobinger, G. (PI)

  GuardRX

  11/1/22 → 1/19/23

  Project: Research project

• Pan-COVID Therapeutic

  Tseng, C.-T. (PI)

  Larix Bioscience LLC

  10/1/22 → 9/29/23

  Project: Research project

• Prophylactic Evaluation of a Nipah Virus Monoclonal Antibody Medical Countermeasure

  Geisbert, T. (PI)

  Mapp Biopharmaceutical, Inc.

  9/27/22 → 8/31/24

  Project: Research project

• Study to Evaluate the Safety, Tolerability and Immunogenicity of INO-4700 for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Healthy Volunteers

  Kobinger, G. (PI)

  GuardRX

  9/15/22 → 11/17/22

  Project: Research project

• Development of a Sudan Ebolavirus Vaccine Utilizing a Live Vesicular Stomatitis Virus Chimera Platform

  Geisbert, T. (PI)

  International AIDS Vaccine Initiative

  9/2/22 → 12/31/23

  Project: Research project

• A Fully Integrated Point-of-Care Test for Ebola

  Geisbert, T. (PI)

  DUKE UNIVERSITY

  9/1/22 → 8/31/24

  Project: Research project

• Determining the mechanism of viral inactivation of J&J oral care products

  Endsley, M. (PI)

  Johnson and Johnson Consumer, Inc

  8/15/22 → 12/31/22

  Project: Research project

• Animal Models for Risk Assessment of Viral Pathogenesis

  Xie, X. (PI)

  Centers for Disease Control and Prevention

  8/5/22 → 2/4/24

  Project: Research project

• Point-of-care antigen detection assay for early diagnosis of Ebola virus disease (EVD)

  Geisbert, T. (PI)

  InBios International

  7/1/22 → 2/28/24

  Project: Research project

• Characterization of the mosquito microbiome and its role in arbovirus emergence in Senegal

  Dickson, L. (PI)

  RTI International

  5/1/22 → 8/8/23

  Project: Research project

• Evaluate the efficacy of a T cell-based human vaccine against CoV-2 Infection

  Tseng, C.-T. (PI)

  Massachusetts Institute of Technology

  4/29/22 → 12/31/22

  Project: Research project

• Marburg Virus Prophylactic Medical Countermeasure

  Geisbert, T. (PI)

  Mapp Biopharmaceutical, Inc.

  4/6/22 → 2/28/23

  Project: Research project

• Multivalent flavivirus vaccine development using a flexible replication RNA platform (Study 2): Mouse vaccine efficacy. Vaccinate mice, verify induction of humoral immunity, challenge with YFV to observe vaccine-induced protection.

  Plante, K. (PI)

  Infectious Disease Research Institute

  4/1/22 → 11/3/22

  Project: Research project

• Efficacy testing of ChAdOx1 vaccine against plague in a NHP model

  Chopra, A. (PI)

  University of Oxford

  3/30/22 → 9/30/23

  Project: Research project

• Intrinsically-Enhanced Ebola Virus Like Particles for Increased Potency and Immune Memory

  Geisbert, T. (PI)

  Icahn School of Medicine at Mount Sinai

  3/24/22 → 5/31/23

  Project: Research project

• Intersection Between Viral Translation and Innate Immunity in the Context of Filovirus Infection

  Geisbert, T. (PI)

  Icahn School of Medicine at Mount Sinai

  3/18/22 → 6/30/24

  Project: Research project

• Inactivation of aerosolized SARS-CoV-2 by Pisharodi devices

  Lawrence, W. (PI)

  South Texas Neurosurgery Associates

  3/1/22 → 9/1/22

  Project: Research project

• Efficacy of iron chelating compound against SARS-CoV-2 infection in mice

  Chopra, A. (PI)

  Livionex, Inc

  2/15/22 → 12/31/22

  Project: Research project

• Multivalent flavivirus vaccine development using a flexible replication RNA platform (Study 1): Verify YFV challenge following transient immune depletion with MAR-1 5A3 IFNAR-1 blocking mAb.

  Plante, K. (PI)

  Infectious Disease Research Institute

  2/15/22 → 9/30/22

  Project: Research project

• Clinical Study Protocol for COVID-19 Antigen Test - Omicron Variant

  Tseng, C.-T. (PI)

  Twist Bioscience Corporation

  1/24/22 → 1/23/23

  Project: Research project

• Development of Antibodies to Treat Omicron Variant

  Weaver, S. (PI)

  Sealy and Smith Foundation

  1/5/22 → 1/4/24

  Project: Research project

• SARS-CoV-2 tropism in the brain and its relationship to COVID-19 pathogenesis

  Tseng, C.-T. (PI)

  University of North Dakota - Grand Forks

  1/1/22 → 7/1/23

  Project: Research project

• Efficacy of Marburg virus monoclonal antibody (IBT-T03) in guinea pig model of MARV-Angola infection

  Geisbert, T. (PI)

  Abvacc

  11/11/21 → 6/30/22

  Project: Research project

• Covid-19 Antiviral Treatment

  Xie, X. (PI)

  Novartis Institute for BioMedical Research

  10/20/21 → 6/1/23

  Project: Research project

• Determination of the EC50 and EC90 of favipiravir against SARS-CoV-2

  Geisbert, T. (PI)

  FUJIFILM Pharmaceutical USA Inc

  10/1/21 → 8/31/22

  Project: Research project

• West African Center for Emerging Infectious Diseases

  Weaver, S. (PI)

  National Institute of Allergy and Infectious Diseases

  9/6/21 → 5/31/23

  Project: Research project

• Pathogenic mechanisms of HIV-associated pain

  Endsley, J. (PI)

  Stony Brook University

  9/3/21 → 8/31/24

  Project: Research project

• SARS-CoV-2 Infected Human Lung Cell Systems with Arbutus Biopharma Corp

  Xie, X. (PI)

  Arbutus Biopharma, Inc

  9/1/21 → 11/15/23

  Project: Research project

• Teixobactin Development for Anthrax

  Lawrence, W. (PI)

  NovoBiotic Pharmaceuticals, LLC

  7/28/21 → 6/30/22

  Project: Research project

• Postdoctoral Fellow: Ping-Hang Huang, PhD

  Tseng, C.-T. (PI)

  EM Foundation

  7/1/21 → 8/31/22

  Project: Research project

• Option 12.2B: SAVE- Variant Pipeline- in vivo models (Weaver) (Mod 2)

  Weaver, S. (PI)

  St. Jude Childrens Research Hospital

  6/1/21 → 3/31/23

  Project: Research project

• In Vitro Lassa Virus Resistance Studies with ARN-75039

  Geisbert, T. (PI)

  Arisan Therapeutics Corporation

  6/1/21 → 6/30/22

  Project: Research project

• Evolution of Anti-Filovirus B Cell Responses and Mechanisms of Protection

  Geisbert, T. (PI)

  Abvacc

  5/18/21 → 5/17/22

  Project: Research project